EPSRC Centres for Doctoral Training in Advanced and Targeted Therapeutics

 
The University of Nottingham
  • Print
  
CDT front page

Advanced Therapeutics& Nanomedicines

 
 

Watch our 'Student View' videoFunded by the Engineering and Physical Sciences Research Council (EPSRC) and in partnership with industry sponsors Alliance Boots, AstraZeneca, GlaxoSmithKline, and Pfizer, the CDT in Advanced Therapeutics & Nanomedicines trains PhD students at the cutting-edge of pharmaceutical science.

It builds on the success of the CDT in Targeted Therapeutics, which was launched in 2005 and funded by the EPSRC as the first CDT with direct collaboration from an industry partner (AstraZeneca). In 2012 the CDT expanded as the University of Nottingham and AstraZeneca were joined in partnership by University College London’s School of Pharmacy and five additional industry partners: Alliance Boots, PfizerGlaxoSmithKline, Quotient Clinical, and Juniper Pharma.

CDT team win Biotechnology YES competition

 
 

EPSRC Centres for Doctoral Training in Advanced & Targeted Therapeutics

The University of Nottingham
School of Pharmacy
Boots Science Building
University of Nottingham, Nottingham, NG7 2RD

t: +44(0)115 823 2121
e: Claudia.Matz@nottingham.ac.uk

University College London
School of Pharmacy
University College London 29-39 Brunswick Square, London WC1N 1AX

t: +44 (0) 20 7753 5948
e: S.Maneechak@ucl.ac.uk